Ovarian Cancer Biomarkers in the COVID-19 Era.

Farina, Antonella; Colaiacovo, Flavia; Gianfrate, Mariacarmela; Pucci, Beatrice; Angeloni, Antonio; Anastasi, Emanuela

Farina, Antonella; Colaiacovo, Flavia; Gianfrate, Mariacarmela; Pucci, Beatrice; Angeloni, Antonio; Anastasi, Emanuela.

Afiliação

Farina A; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Colaiacovo F; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Gianfrate M; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Pucci B; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Angeloni A; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Anastasi E; Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Int J Environ Res Public Health ; 20(11)2023 05 29.

Article em En | MEDLINE | ID: mdl-37297598

Assuntos

COVID-19; Neoplasias Ovarianas; Humanos; Feminino; Biomarcadores Tumorais; Reprodutibilidade dos Testes; Proteína 2 do Domínio Central WAP de Quatro Dissulfetos; COVID-19/diagnóstico; SARS-CoV-2; Neoplasias Ovarianas/diagnóstico; Curva ROC

Palavras-chave

HE4; SARS-CoV-2; ovarian cancer; tumor markers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google